SaintNectar
@saintnectar.bsky.social
Swing Trader | CANSLIM disciple analyzing fundamentals and hunting for the next market leaders. I focus on institutional quality and high-growth stocks
NVO EPS: +31→+31→+15→+21→+11→+7%.
Sales: +28→+22→+20→+24→+11→+5%.
Down 49%.
But FDA restricting compounded GLP-1s + Wegovy pill on TrumpRx & Amazon could stem the bleeding. New CEO may be sandbagging '26 estimates to beat & raise.
Sales: +28→+22→+20→+24→+11→+5%.
Down 49%.
But FDA restricting compounded GLP-1s + Wegovy pill on TrumpRx & Amazon could stem the bleeding. New CEO may be sandbagging '26 estimates to beat & raise.
February 7, 2026 at 3:59 PM
NVO EPS: +31→+31→+15→+21→+11→+7%.
Sales: +28→+22→+20→+24→+11→+5%.
Down 49%.
But FDA restricting compounded GLP-1s + Wegovy pill on TrumpRx & Amazon could stem the bleeding. New CEO may be sandbagging '26 estimates to beat & raise.
Sales: +28→+22→+20→+24→+11→+5%.
Down 49%.
But FDA restricting compounded GLP-1s + Wegovy pill on TrumpRx & Amazon could stem the bleeding. New CEO may be sandbagging '26 estimates to beat & raise.